Skip to main content
XTL Biopharmaceuticals Ltd. logo

XTL Biopharmaceuticals Ltd. — Investor Relations & Filings

Ticker · XTLB ISIN · IL0010854979 LEI · 529900NDDXEAPTUTXP41 TA Manufacturing
Open in API
Filings indexed 1,223 across all filing types
Latest filing 2014-09-28 Regulatory Filings
Country IL Israel
Listing TA XTLB

About XTL Biopharmaceuticals Ltd.

https://www.xtlbio.com

XTL Biopharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on the acquisition and development of pharmaceutical products to address unmet clinical needs. The company's primary therapeutic area of interest is autoimmune diseases. Its development pipeline has included proprietary drug candidates for conditions such as Systemic Lupus Erythematosus (SLE).

Recent filings

Filing Released Lang Actions
Immediate Report
Regulatory Filings
2014-09-28 Hebrew (modern)
Immediate Report
Capital/Financing Update Classification · 98% confidence The document is an 'Immediate Report' filed with the Israel Securities Authority and the Tel Aviv Stock Exchange. The key content states: 'Attached hereto is a report on *PRELIMINARY PROSPECTUS SUPPLEMENT*'. A Preliminary Prospectus Supplement relates to the offering of securities, which falls under financing activities or capital structure changes. Given the short length (1640 chars) and the explicit mention that a document (*PRELIMINARY PROSPECTUS SUPPLEMENT*) is attached, this filing is an announcement about a capital/financing event rather than the full prospectus itself. This aligns best with the 'Capital/Financing Update' category (CAP).
2014-09-28 English
Immediate Report
Regulatory Filings
2014-09-28 Hebrew (modern)
Immediate Report
Report Publication Announcement Classification · 98% confidence The document is very short (1619 characters) and explicitly states, "Attached hereto is a report on *XTL_FWP_SEP_2014_isa.pdf*". This structure—a brief announcement stating that a report is attached or published, rather than containing the full report content—fits the definition of a Report Publication Announcement (RPA). It is not a full financial report (like 10-K or IR) or a transcript (CT). The reference to the Israel Securities Authority and the format suggests a regulatory filing context, but the specific action described is the publication announcement.
2014-09-28 English
ISSUER FREE WRITING PROSPECTUS
Regulatory Filings
2014-09-26 English
424B5
Regulatory Filings
2014-09-26 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.